Taejon, South Korea

Hosung Sohn

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2009-2011.



Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2009-2011

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Cancer Diagnosis by Hosung Sohn

Introduction

Hosung Sohn is a notable inventor based in Taejeon-si, South Korea. He has made significant contributions to the field of cancer diagnosis through his innovative methods and diagnostic kits. With a total of two patents to his name, his work focuses on the critical area of tumorigenesis and metastasis.

Latest Patents

Hosung Sohn's latest patents include a method for the diagnosis of cancers by measuring the changes of glycosylation of proteins related to tumorigenesis and metastasis. This invention also encompasses a diagnostic kit that utilizes this method. The method is particularly effective for diagnosing various types of cancers, including colon cancer, stomach cancer, lung cancer, and liver cancer. By measuring the changes in glycosylation of proteins, this innovative approach offers a sensitive and reliable means of cancer diagnosis.

Career Highlights

Hosung Sohn is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he continues to advance research in cancer diagnostics. His work has the potential to significantly impact the early detection and treatment of cancer, improving patient outcomes.

Collaborations

Some of his notable coworkers include Jeong Heon Ko and Soo Young Hwang, who contribute to the collaborative efforts in research and development within the institute.

Conclusion

Hosung Sohn's innovative methods and diagnostic kits represent a significant advancement in cancer diagnosis. His contributions are vital in the ongoing fight against cancer, showcasing the importance of research and innovation in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…